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ABSTRACT
Background The adult smoking prevalence has declined
more in California than the rest of the US in the past
2 decades. Further, California has faster declines in
cancer mortality, lung cancer incidence and heart
disease mortality. However, no study has examined
smoking-related cancer mortality between California and
the rest of the US.
Methods The smoking-attributable cancer mortality rate
(SACMR) from 1979 to 2005 in California and the rest of
the US are calculated among men and women 35 years
of age or older using the Joinpoint regression model to
calculate the SACMR annual percentage change. The
SACMR is the sum of the smoking-attributable death
rates of 10 smoking-attributable cancers.
Results The SACMR has declined more in California
(25.7%) than the rest of the US (8.9%) from 1979 to
2005. California men had a lower SACMR than the rest
of the US over the entire study period, with the
difference tripling from 7.4% in 1979 to 23.9% in 2005.
The difference of female SACMR between California and
the rest of the US went from 17.9% higher in 1979 to
13.4% lower in 2005.
Conclusions California’s SACMR decrease started
7 years earlier than the rest of the US (1984 vs 1991),
and California experienced an accelerated decline of
SACMR compared to the rest of the US overall and
among men and women from 1979 to 2005. Although
the SACMR started declining before the creation of the
California Department of Public Health, California
Tobacco Control Program, the SACMR rate of decline in
California accelerated after the programme’s inception.
INTRODUCTION
Previous studies show that trends in smoking-
attributable mortality can be a good reﬂection of
the smoking prevalence change pattern over a long
period of time.
1e5 Smoking-attributable mortality
has been used as a marker to determine and
evaluate tobacco control efforts.
6e8 California was
the ﬁrst state to initiate a statewide comprehensive
tobacco control programme in 1989 that included
social, regulatory and environmental strategies.
9
This approach in California has led to a signiﬁ-
cantly lower and faster decline in adult smoking
prevalence in California than in the rest of the
US.
10 The smoking prevalence among California
adults has dropped by 46.5%, from 25.8% in 1984
to 13.8% in 2007.
11 In comparison, the US preva-
lence based on the National Health Interview
Survey (NHIS) has decreased approximately 38.6%,
from 32.1% in 1983 to 19.7% in 2007.
12
Because smokers that smoke fewer cigarettes per
day are at a lower risk of disease,
13 especially for
lung cancer or heart disease, on a population level
a noticeable change in smoking-related diseases
should be observable when cigarette consumption
declines. Cigarette consumption has also decreased
faster in California and is currently half the number
of the rest of the US.
11 Adult per capita cigarette
consumption decreased by 75%, from 160 in 1980
to 40 in 2006, whereas the rest of the US decreased
by 55%, from 183 in 1980 to 82 in 2006.
11
This change in population-level smoking behav-
iour over time has correlated with better health
outcomes. Heart disease mortality has been shown
to be decreasing faster in California than in the rest
of the US,
14 while lung cancer incidence and
mortality have been shown to have peaked and are
declining faster in California than the rest of the
US.
15 Between 2001 and 2005, lung cancer inci-
dence among women decreased in only one state:
California.
16 The male lung cancer death rate in
California peaked ﬁrst and is decreasing at such
a rate that the death rate is approaching that of
Utah.
16 Although these long-term health outcomes
are a lagging indicator of various tobacco control
policies, which makes speciﬁc intervention attri-
bution difﬁcult, these lung cancer declines have
been related to the California Department of Public
Health, California Tobacco Control Program
(CTCP).
17
Smokingcausesabout85%ofthelungcancercases.
Lung cancer mortality is a speciﬁc measure of the
smoking impact on health outcomes.
16 18 Nine other
cancers are also caused by smoking.
18 19 Therefore,
the total smoking impact on cancer mortality can be
measured by the smoking-attributable death rate of
the 10 cancers in total, even though these cancers
have vastly different aetiologies, develop at different
rates and are less attributable to smoking. Our goal
was to simply examine the trends in smoking-
attributable cancer mortality from 1979 to 2005 in
California and the rest of the US.
METHODS
Study population
To evaluate the smoking impact on cancer
mortality change over time, this study compared
the smoking-attributable cancer mortality rate
(SACMR) change in California and the rest of the
US from 1979 to 2005. We examined the SACMR of
adults aged 35 years or older.
Smoking status
Smoking status data came from the NHIS from
1979 to 2005. Current smokers included current
daily smokers or some day smokers who reported
having smoked at least 100 cigarettes during their
lifetime. Never smokers were deﬁned as those who
reported having smoked less than 100 cigarettes
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Research paperduring their lifetime. Former smokers referred to those who
smoked at least 100 cigarettes during their lifetime but did not
smoke currently. Details about the survey methodology have
been published elsewhere.
20 The NHIS did not collect smoking
data in the years 1981, 1982, 1984, 1986, 1989 and 1996. We
applied the ‘loess’ method using R
21 to model smoking preva-
lence in those years and to smooth the prevalence trends. R is an
integrated suite of statistical software for data manipulation,
calculation and graphical display.
Cancer mortality
A total of 10 types of smoking-related cancers were included to
calculate the SACMR, including lip/oral cavity/pharynx,
oesophagus, stomach, pancreas, larynx, trachea/lung/bronchus,
cervix uteri (for women only), kidney/renal pelvis, urinary
bladder and acute myeloid leukaemia. The age-adjusted death
rates of each cancer for men and women aged 35 years or older
came from the Surveillance, Epidemiology, and End Results
(SEER) programme.
22 We used the SEER*Stat software
package
23 to retrieve annual death rates of the 10 cancers in
California and the rest of the US during 1979e2005. The cancer
death rates from the SEER programme were derived from death
certiﬁcate data maintained by the National Center for Health
Statistics. We standardised the cancer death rates in each
calendar year to the 2000 US Census population for direct
comparison over years between California and the rest of
the US.
Smoking-attributable fraction
The smoking-attributable fraction (SAF) is the maximal
proportion of cancer deaths causally linked to cigarette smoking.
The calculation of the SAF for each cancer requires sex-speciﬁc
current and former cigarette smoking prevalence and sex-speciﬁc
RR of the 10 cancers in relation to smoking status. The formula
(equation 1) for calculating the SAF, developed by the adult
Smoking-Attributable Mortality, Morbidity, and Economic
Costs (SAMMEC) software,
24 was derived from attributable risk
formulae to account for the different levels of exposure for
current smokers and former smokers as indicated by separate
prevalence rates and relative risk estimates:
SAF ¼
ðp0 þ p13RR1 þ p23RR2

  1
p0 þ p13RR1 þ p23RR2
(1)
where p0 is the percentage of never smokers (persons who
have smoked <100 cigarettes), p1 is the percentage of current
smokers (persons who have smoked $100 cigarettes and now
smoke every day or some days), p2 is the percentage of former
smokers (persons who have smoked $100 cigarettes and do not
currently smoke), RR1 is the relative risk for current smokers
relative to never smokers, and RR2 is the relative risk for former
smokers relative to never smokers.
The relative risks of the 10 cancers were estimated and
provided by the American Cancer Society (ACS) based on data
from ACS’s Cancer Prevention Study II.
25 The RRs were calcu-
lated as the ratio of cancer death rate for current or former
smokers relative to cancer death rate for never smokers among
adults aged 35 years or older.
Prevalence of current, former and never smokers came from
the above-mentioned NHIS survey. Because the NHIS survey did
not provide data to calculate smoking rates in California and the
rest of the US separately, the national smoking rates were used
to calculate the smoking-attributable fraction.
SACMR
We used methods similar to those described in the adult
SAMMEC software
24 to estimate the SACMR. This was the
sum of smoking-attributable death rates due to the above-
mentioned 10 cancers. The smoking-attributable death rate was
calculated by multiplying the death rate of a cancer by the
estimated SAF of the cancer. Male and female SACMRs were
calculated separately, and a simple average of the two was
calculated to represent the overall population in California and
the rest of the US.
Annual percentage change
To better compare the SACMR trend of California to that of the
rest of the US during 1979e2005, we applied the Joinpoint
regression model to identify the signiﬁcant change points and to
report the annual percentage change (APC) between the iden-
tiﬁed points. The Joinpoint regression interpreted changes over
time more accurately and determined if those changes were
statistically signiﬁcant. We used the Joinpoint regression
program V.3.3
26 to ﬁt the Joinpoint regression models. The
program took the SACMR trend data in 1979e2005 and ﬁtted
a series of straight lines to the SACMR on the log scale. The
straight lines were connected together at the year of ‘joinpoints’.
Each joinpoint year denoted a statistically signiﬁcant (p#0.05)
change in trend. The tests of signiﬁcance used the Monte Carlo
permutation method to ﬁnd the ‘best ﬁt’ line for each time
period deﬁned by the joinpoint years.
27 The program started
with the minimum number of joinpoint (eg, 0 joinpoints, which
is a straight line) and tested whether more joinpoints were
statistically signiﬁcant and must be added to the model (up to
that maximum number). The program provided model ﬁtting
results and one graph for each joinpoint model, from the model
with the minimum number of joinpoints to the model with
maximum number of joinpoints. The program also marked
a model with the optimum number of joinpoints, which we
used as the ﬁnal model to best describe the SACMR trends in
California and the rest of the US during 1979e2005. In addition,
the program provided the annual percentage change of SACMR
and its 95% CI over each time period deﬁned by the joinpoint
years.
28 The annual percentage change summarised the SACMR
trend between two joinpoint years. More details of the Joinpoint
Regression Program can be found at http://srab.cancer.gov/
joinpoint/. We compared the joinpoint years and the APC values
of the SACMR during 1979e2005 between California and the
rest of the US.
RESULTS
Due to the continuous smoking prevalence drop over the past
2 decades,
23 the SACMR decreased in California and in the rest
of the US as expected. Overall, the SACMR dropped 25.7% in
California, from 126.2 per 100000 in 1979 to 93.8 in 2005, while
the SACMR in the rest of the US dropped 8.9%, from 129.4 per
100000 to 117.9 during the same period (table 1). The SACMR
in California was only 2.5% lower than that in the rest of the US
in 1979, but was 20.4% lower than that in the rest of the US in
2005.
The SACMR increased in California and the rest of the US at
the beginning of 1980s. SACMR started to decrease in 1984 in
California, 7 years earlier than the rest of the US in which the
decrease did not occur until 1991 (ﬁgure 1). The Joinpoint
regression model indicated an accelerated decrease of SACMR in
California since 1984 but a slower decrease in the rest of the US
since 1991. The APC in California was  1.1% (95% CI  1.5% to
 0.7%) from 1984 to 1994, which accelerated to  2.6% (95% CI
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of the US was  1.8% (95% CI  1.9% to  1.7%) from 1991 to
2005 (table 2).
Over the entire time period, California men had a lower
SACMR than the rest of the US, with the difference tripled from
7.4% in 1979 to 23.9% in 2005 (table 3). The SACMR of Cali-
fornian men decreased continuously over the entire period, with
an accelerated APC which increased more than four times, from
 0.9% (95% CI  1.5% to  0.2%) in 1979e1988 to  3.7% (95%
CI  3.9% to  3.5%) in 1988e2005. Different from the mono-
tonic decrease of the Californian male SACMR, the SACMR for
the rest of US males did not decrease (APC 0.2%, 95% CI 0.0% to
0.4% during 1979e1991) until 1991 (APC  3.6%, 95% CI  3.7%
to  3.5% during 1991e2005).
The female SACMR in California was 17.9% higher than the
rest of the US in 1979. It changed to 13.4% lower than the rest
of the US in 2005 due to an earlier and faster decline started in
1993. California and the rest of the US experienced an increase of
the female SACMR in the 1980s and early 1990s before the start
of a decrease. The APC in California was 2.2% (95% CI 1.8% to
2.7%) in 1979e1984, slowed down to 0.7% in 1984e1993 (95%
CI 0.4% to 0.9%), then started to decrease signiﬁcantly with
APC accelerating from  0.9% (95% CI  1.2% to  0.7%) in
1993e2001 to  1.9% (95% CI  2.5% to  1.4%) in 2001e2005.
Similar to California, the APC of SACMR increase in the rest of
the US was 1.8 (95% CI 1.7% to 1.9%) in 1979e1991, and also
slowed down to 0.7% (95% CI 0.2% to 1.1%) in 1991e1996.
However, the SACMR in the rest of the US levelled off in
1996e2002 (APC  0.1%, 95% CI  0.4% to 0.2%), while Cali-
fornia was experiencing the SACMR decline. The rest of the US
did not experience the SACMR decline until 2002 (APC  1.0%,
95% CI  1.6% to 0.4% in 2002e2005).
DISCUSSION
The aggregate measure of tobacco cancer mortality burden in
California and the rest of the US strengthen the previous ﬁnd-
ings that smoking-related health outcomes are currently
different in California than the rest of the US. Although some
health outcomes could be inﬂuenced by tobacco control
measures in the short term, the SACMR is a longer-term
measure with the complete underlying effects of changes in
smoking behaviour playing out over decades. Nevertheless,
noticeable effects could be expected to be observable in the ﬁrst
decade.
17 The SACMR is a complex function of a variety of
factors, including initiation and cessation-related cohort effects
and survival rates for the smoking-related cancers.
After the latest change point, the SACMR for men in Cali-
fornia and the rest of the US are on similar percentage declines.
The primary difference in the trends are that the California was
already declining prior to the change point and that the latest
change point occurred in 1988 compared to 1991 in the rest of
the US. This has resulted in a continuous offset in the SACMR
of about 36 per 100000 or 23% since 1991.
For women, the SACMR in California stopped rising as fast
and peaked earlier in California in comparison to the rest of the
US. From 2001 to 2005, the California SACMR for women
doubled the previous rate of decline from 1993 to 2001.
Although not following the exact trend pattern, the rest of the
US’s SACMR trend has followed the California trend with
a delay of roughly 10 years.
The difference and earlier peak in SACMR between California
and the rest of the US may partially be related to California’s
smoking behaviour changes occurring earlier in California than
the rest of the US.
10 29 30 The accelerated declines of smoking
prevalence and smoking consumption in California occurred in
the late 1980s. They are partially a result of California’s Prop-
osition 99 in 1988, which raised the excise tax on a pack of
cigarettes by $0.25 and established CTCP.
31
This study has several limitations. The cancer death rate
derived from death certiﬁcates has reporting inaccuracy,
although the reporting accuracy of cancers is better than other
diseases.
32 33 The change of death cause coding from the Inter-
national Classiﬁcation Of Disease (ICD) from ICD-9 to ICD-10
in 1999 may have caused discontinuing mortality trends over
years.
34 35 SAFs are treated as known quantities in the analysis
although the relative risks and smoking prevalence used to
calculate them are based on estimates. Due to a lack of
comparable data of smoking prevalence between California and
the rest of the US, SAFs were calculated using the national
smoking prevalence from the NHIS instead of California speciﬁc
data. Because smoking-attributable cancer deaths play out over
a long period of time
36 and SACMRs are derived from current
year smoking prevalence, reported SACMR may have been
underestimated, given that smoking rates in previous years were
much higher and may have biased the SACMR trend to certain
extent. The cancer mortality caused by secondhand smoking
was not included in the SACMR computation. The APC of
SACMR was statistically tested between time periods within
California and the rest of the US but not between the two. Due
to the limitations of the Joinpoint regression program, we could
not set up the same set of points for a direct comparison
between California and the rest of the US. Potential
Table 1 Smoking-attributable cancer mortality rate (SACMR) and 95%
CI among adults aged 35 years or older in California and the rest of the
USA, 1979e2005
Year
California Rest of the USA
SACMR 95% CI SACMR 95% CI
1979 126.2 125.4 to 126.9 129.4 129.2 to 129.7
1980 128.5 127.7 to 129.3 131.9 131.7 to 132.2
1981 129.9 129.1 to 130.7 132.4 132.1 to 132.6
1982 131.9 131.1 to 132.7 134.5 134.2 to 134.7
1983 131.1 130.3 to 131.8 135.4 135.2 to 135.7
1984 133.2 132.5 to 134.0 136.7 136.4 to 136.9
1985 131.7 131.0 to 132.4 137.2 137.0 to 137.4
1986 129.6 128.9 to 130.2 138.1 137.8 to 138.3
1987 130.2 129.5 to 130.9 139.3 139.0 to 139.5
1988 130.7 130.1 to 131.4 139.7 139.5 to 140.0
1989 129.1 128.5 to 129.8 141.1 140.9 to 141.4
1990 128.5 127.9 to 129.1 142.5 142.3 to 142.7
1991 127.0 126.4 to 127.6 142.2 141.9 to 142.4
1992 123.2 122.6 to 123.8 140.9 140.7 to 141.1
1993 123.4 122.8 to 123.9 140.5 140.3 to 140.7
1994 122.2 121.7 to 122.8 138.3 138.1 to 138.5
1995 120.2 119.6 to 120.7 137.0 136.8 to 137.2
1996 116.3 115.8 to 116.9 135.4 135.2 to 135.6
1997 115.4 114.9 to 115.9 133.5 133.3 to 133.7
1998 110.7 110.2 to 111.2 132.3 132.1 to 132.5
1999 109.5 109.1 to 110.0 127.7 127.6 to 127.9
2000 106.0 105.6 to 106.4 127.8 127.7 to 128.0
2001 106.4 105.9 to 106.8 125.9 125.7 to 126.1
2002 102.8 102.4 to 103.2 124.2 124.1 to 124.4
2003 98.7 98.3 to 99.1 121.8 121.7 to 122.0
2004 95.3 94.9 to 95.7 119.6 119.5 to 119.8
2005 93.8 93.4 to 94.2 117.9 117.7 to 118.0
SACMR is presented as number of cases per 100 000. The included smoking attributable
cancers are: lip, oral cavity, pharynx; oesophagus, stomach; pancreas; larynx; trachea, lung,
bronchus; cervix uteri (for women only); kidney and renal pelvis; urinary bladder; and acute
myeloid leukaemia. The age-adjusted cancer death rates in each calendar year were
standardised to the 2000 US Census population.
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have inﬂuenced the smoking exposure, cancer mortality and
relative risk of smoking in relation to cancer mortality, were not
tested and controlled. Also, this study does not draw a direct
correlation between CTCP or the changes in smoking behaviour
and the outcome (smoking-attributable cancer mortality).
Lastly, the large Latino and Asian populations in California
with their lower smoking prevalence, particularly among
Figure 1 Smoking-attributable cancer
mortality rate (SACMR) among adults
aged 35 years or older in California and
the result of the USA, 1979e2005.
Table 2 Annual percentage change and 95% CI of smoking-attributable cancer mortality rate (SACMR) among adults aged 35 years or older in
California and the rest of the USA: Joinpoint regression results
California Rest of the USA
Joinpoint Years (range) APC (%) 95% CI Joinpoint Years (range) APC (%) 95% CI
Overall 1984 1979e1984 1.3 0.2 to 2.4 1991 1979e1991 1.1 1.0 to 1.2
1994 1984e1994 L1.1  1.5 to  0.7 1991e2005 L1.8  1.9 to  1.7
1994e2005 L2.6  2.8 to  2.4
Male 1988 1979e1988 L0.9  1.5 to  0.2 1991 1979e1991 0.2 0.0 to 0.4
1988e2005 L3.7  3.9 to  3.5 1991e2005 L3.6  3.7 to  3.5
Female 1984 1979e1984 2.2 1.8 to 2.7 1991 1979e1991 1.8 1.7 to 1.9
1993 1984e1993 0.7 0.4 to 0.9 1996 1991e1996 0.7 0.2 to 1.1
2001 1993e2001 L0.9  1.2 to  0.7 2002 1996e2002  0.1  0.4 to 0.2
2001e2005 L1.9  2.5 to  1.4 2002e2005  1.0  1.6 to 0.4
Bold numbers are statistically different from 0 at the 5% level.
APC, annual percentage change.
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fornia compared to the rest of the US. Hispanics and Asian/
Paciﬁc Islanders have a lower incidence of lung cancer than non-
Hispanic whites. They might also have different susceptibilities
to the smoking-attributable cancers.
37 38 However, we have seen
similar declines in lung cancers between AfricaneAmericans and
non-Hispanic whites, but a slower decline among Hispanics and
Asian/Paciﬁc Islanders from 1988 to 2005.
39 Additionally, the
observed decline among Hispanics and Asian/Paciﬁc Islanders
was not different between California and the rest of the US
during 1990e2005.
40 Consequently, the faster decline of overall
SACMR in California is unlikely to be due to the different racial/
ethnic mix in California.
Although the ecological correlations that we observe do not
prove a causal relationship between any particular tobacco
control intervention and the decrease in cancer death rate, the
enlarging discrepancy between California and the rest of the US
in recent years suggests a result due to the long-term and
ongoing tobacco control programme in California.
Tobacco control efforts in California have taken hold and led to
a social norm change that has led to a noticeable difference in
smokingbehavioursinCalifornia.Inturn,thesechangesappearto
have led to differences in heart disease, lung cancer and smoking-
attributable cancer mortality. These results are an optimistic sign
that the restof the US will also start beneﬁting from national and
the sustained state tobacco control efforts in other states.
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What this paper adds
A number of studies have shown that California has seen
a decline in smoking related health outcomes, including lung
cancer incidence and mortality and heart disease mortality, in
comparison to the rest of the nation. This is the ﬁrst study that
compares the smoking-attributable cancer mortality (SACMR)
change between California and the rest of the United States from
1979 to 2005. The study reveals that the SACMR decease in
California started 7 years earlier than the rest of the United
States. Additionally, this decline in California is faster than the
rest of the United States among men, women and combined.
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